Inappropriate Antibiotic Prescribing in Primary Healthcare Facilities in China: a Nationwide Survey, 2017-2019.

Mengyuan Fu,Zhiwen Gong,Yuezhen Zhu,Can Li,Yue Zhou,Lin Hu,Huangqianyu Li,Haishaerjiang Wushouer,Xiaodong Guan,Luwen Shi

DOI: https://doi.org/10.1016/j.cmi.2022.11.015

IF: 13.31

2023-01-01

Clinical Microbiology and Infection

Abstract:Objectives: We aimed to generate comprehensive estimates of the appropriateness of outpatient antibiotic prescriptions at primary healthcare facilities (PHFs) in China.Methods: Between 2017 and 2019, we collected outpatient-visit prescriptions from 269 Chinese PHFs in 31 cities located in 6 provinces. Conditions that resulted in antibiotic use were classified into appropriate, potentially appropriate, and inappropriate using a well-established classification approach. We then assessed the magnitude, appropriateness, and costs of antibiotic prescribing, overall and by antibiotic classification group, diagnostic categories, and patient characteristics.Results: Of all eligible 209 662 antibiotic prescriptions, 147 758 (70.5%) were inappropriate, which accounted for 66.8% (558.0/835.3 thousand US dollars) of costs for antibiotics. Upper respiratory tract infections, acute bronchitis, and non-infectious gastroenteritis were responsible for 68.9% (101 744/ 147 758) of inappropriately antibiotic prescriptions. High inappropriate antibiotic prescribing rates were observed among children aged 0-5 years (78.5% (21 049/26 799)) and patients living in economically undeveloped areas (77.5% (38 430/49 587)). A total of 256 474 individual antibiotics were prescribed, of which 82.2% (210 885/256 474) were broad-spectrum antibiotics, with second-generation cephalosporins (15.1% (38 705/256 474)) and third-generation cephalosporins (14.6% (37 491/256 474)) being the most commonly prescribed subgroups.Discussion: Our findings highlight the excessive and inappropriate use of antibiotics in Chinese PHFs pending multidimensional efforts. Mengyuan Fu, Clin Microbiol Infect 2023;29:602 (c) 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.